Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?

The development and testing of new antimicrobial peptides (AMPs) represent an important milestone toward the development of new antimicrobial drugs that can inhibit the growth of pathogens and multidrug-resistant microorganisms such as <i>Pseudomonas aeruginosa,</i> Gram-negative bacteri...

Full description

Bibliographic Details
Main Authors: Sergei Y. Grishin, Pavel A. Domnin, Sergey V. Kravchenko, Viacheslav N. Azev, Leila G. Mustaeva, Elena Y. Gorbunova, Margarita I. Kobyakova, Alexey K. Surin, Maria A. Makarova, Stanislav R. Kurpe, Roman S. Fadeev, Alexey S. Vasilchenko, Victoria V. Firstova, Svetlana A. Ermolaeva, Oxana V. Galzitskaya
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/18/9776
_version_ 1797519002763788288
author Sergei Y. Grishin
Pavel A. Domnin
Sergey V. Kravchenko
Viacheslav N. Azev
Leila G. Mustaeva
Elena Y. Gorbunova
Margarita I. Kobyakova
Alexey K. Surin
Maria A. Makarova
Stanislav R. Kurpe
Roman S. Fadeev
Alexey S. Vasilchenko
Victoria V. Firstova
Svetlana A. Ermolaeva
Oxana V. Galzitskaya
author_facet Sergei Y. Grishin
Pavel A. Domnin
Sergey V. Kravchenko
Viacheslav N. Azev
Leila G. Mustaeva
Elena Y. Gorbunova
Margarita I. Kobyakova
Alexey K. Surin
Maria A. Makarova
Stanislav R. Kurpe
Roman S. Fadeev
Alexey S. Vasilchenko
Victoria V. Firstova
Svetlana A. Ermolaeva
Oxana V. Galzitskaya
author_sort Sergei Y. Grishin
collection DOAJ
description The development and testing of new antimicrobial peptides (AMPs) represent an important milestone toward the development of new antimicrobial drugs that can inhibit the growth of pathogens and multidrug-resistant microorganisms such as <i>Pseudomonas aeruginosa,</i> Gram-negative bacteria. Most AMPs achieve these goals through mechanisms that disrupt the normal permeability of the cell membrane, which ultimately leads to the death of the pathogenic cell. Here, we developed a unique combination of a membrane penetrating peptide and peptides prone to amyloidogenesis to create hybrid peptide: “cell penetrating peptide + linker + amyloidogenic peptide”. We evaluated the antimicrobial effects of two peptides that were developed from sequences with different propensities for amyloid formation. Among the two hybrid peptides, one was found with antibacterial activity comparable to antibiotic gentamicin sulfate. Our peptides showed no toxicity to eukaryotic cells. In addition, we evaluated the effect on the antimicrobial properties of amino acid substitutions in the non-amyloidogenic region of peptides. We compared the results with data on the predicted secondary structure, hydrophobicity, and antimicrobial properties of the original and modified peptides. In conclusion, our study demonstrates the promise of hybrid peptides based on amyloidogenic regions of the ribosomal S1 protein for the development of new antimicrobial drugs against <i>P. aeruginosa</i>.
first_indexed 2024-03-10T07:36:11Z
format Article
id doaj.art-d9e0cb03cf0c4415a055197df5947c5e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T07:36:11Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d9e0cb03cf0c4415a055197df5947c5e2023-11-22T13:27:23ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-09-012218977610.3390/ijms22189776Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?Sergei Y. Grishin0Pavel A. Domnin1Sergey V. Kravchenko2Viacheslav N. Azev3Leila G. Mustaeva4Elena Y. Gorbunova5Margarita I. Kobyakova6Alexey K. Surin7Maria A. Makarova8Stanislav R. Kurpe9Roman S. Fadeev10Alexey S. Vasilchenko11Victoria V. Firstova12Svetlana A. Ermolaeva13Oxana V. Galzitskaya14Institute of Protein Research, Russian Academy of Sciences, 142290 Pushchino, RussiaGamaleya Research Centre of Epidemiology and Microbiology, 123098 Moscow, RussiaInstitute of Environmental and Agricultural Biology (X-BIO), Tyumen State University, 625003 Tyumen, RussiaThe Branch of the Institute of Bioorganic Chemistry, Russian Academy of Sciences, 142290 Pushchino, RussiaThe Branch of the Institute of Bioorganic Chemistry, Russian Academy of Sciences, 142290 Pushchino, RussiaThe Branch of the Institute of Bioorganic Chemistry, Russian Academy of Sciences, 142290 Pushchino, RussiaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, RussiaInstitute of Protein Research, Russian Academy of Sciences, 142290 Pushchino, RussiaState Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, RussiaInstitute of Protein Research, Russian Academy of Sciences, 142290 Pushchino, RussiaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, RussiaInstitute of Environmental and Agricultural Biology (X-BIO), Tyumen State University, 625003 Tyumen, RussiaState Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, RussiaGamaleya Research Centre of Epidemiology and Microbiology, 123098 Moscow, RussiaInstitute of Protein Research, Russian Academy of Sciences, 142290 Pushchino, RussiaThe development and testing of new antimicrobial peptides (AMPs) represent an important milestone toward the development of new antimicrobial drugs that can inhibit the growth of pathogens and multidrug-resistant microorganisms such as <i>Pseudomonas aeruginosa,</i> Gram-negative bacteria. Most AMPs achieve these goals through mechanisms that disrupt the normal permeability of the cell membrane, which ultimately leads to the death of the pathogenic cell. Here, we developed a unique combination of a membrane penetrating peptide and peptides prone to amyloidogenesis to create hybrid peptide: “cell penetrating peptide + linker + amyloidogenic peptide”. We evaluated the antimicrobial effects of two peptides that were developed from sequences with different propensities for amyloid formation. Among the two hybrid peptides, one was found with antibacterial activity comparable to antibiotic gentamicin sulfate. Our peptides showed no toxicity to eukaryotic cells. In addition, we evaluated the effect on the antimicrobial properties of amino acid substitutions in the non-amyloidogenic region of peptides. We compared the results with data on the predicted secondary structure, hydrophobicity, and antimicrobial properties of the original and modified peptides. In conclusion, our study demonstrates the promise of hybrid peptides based on amyloidogenic regions of the ribosomal S1 protein for the development of new antimicrobial drugs against <i>P. aeruginosa</i>.https://www.mdpi.com/1422-0067/22/18/9776ribosomal S1 proteinamyloidantimicrobial peptides<i>Pseudomonas aeruginosa</i>cell penetrating peptide
spellingShingle Sergei Y. Grishin
Pavel A. Domnin
Sergey V. Kravchenko
Viacheslav N. Azev
Leila G. Mustaeva
Elena Y. Gorbunova
Margarita I. Kobyakova
Alexey K. Surin
Maria A. Makarova
Stanislav R. Kurpe
Roman S. Fadeev
Alexey S. Vasilchenko
Victoria V. Firstova
Svetlana A. Ermolaeva
Oxana V. Galzitskaya
Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?
International Journal of Molecular Sciences
ribosomal S1 protein
amyloid
antimicrobial peptides
<i>Pseudomonas aeruginosa</i>
cell penetrating peptide
title Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?
title_full Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?
title_fullStr Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?
title_full_unstemmed Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?
title_short Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of <i>P. aeruginosa</i>?
title_sort is it possible to create antimicrobial peptides based on the amyloidogenic sequence of ribosomal s1 protein of i p aeruginosa i
topic ribosomal S1 protein
amyloid
antimicrobial peptides
<i>Pseudomonas aeruginosa</i>
cell penetrating peptide
url https://www.mdpi.com/1422-0067/22/18/9776
work_keys_str_mv AT sergeiygrishin isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT paveladomnin isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT sergeyvkravchenko isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT viacheslavnazev isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT leilagmustaeva isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT elenaygorbunova isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT margaritaikobyakova isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT alexeyksurin isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT mariaamakarova isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT stanislavrkurpe isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT romansfadeev isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT alexeysvasilchenko isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT victoriavfirstova isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT svetlanaaermolaeva isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai
AT oxanavgalzitskaya isitpossibletocreateantimicrobialpeptidesbasedontheamyloidogenicsequenceofribosomals1proteinofipaeruginosai